INOVIO PHARMACEUTICALS INC. news, videos and press releases
For more news please use our advanced search feature.
INOVIO PHARMACEUTICALS INC. - More news...
INOVIO PHARMACEUTICALS INC. - More news...
- INOVIO Announces Pricing of $30 Million Public Offering
- INOVIO Announces Proposed Public Offering
- New Retrospective Data Shows Half of RRP Patients Treated with INO-3107 Achieved a Complete Response When Evaluated 2 and 3 Years Following Initial Phase 1/2 Trial
- INOVIO Reports Inducement Grant Under Inducement Plan
- INOVIO Reports Third Quarter 2024 Financial Results and Recent Business Highlights
- Immunology Data Shows INOVIO's INO-3107 Induced Expansion of New Clonal T Cells That Infiltrate Airway Tissue and Correspond With Reduction of Surgeries for RRP Patients Observed in Phase 1/2 Trial
- INOVIO to Present at Upcoming Scientific Conferences
- INOVIO to Report Third Quarter 2024 Financial Results on November 14, 2024
- INOVIO Announces New Data at Scientific Conferences for Lead Candidate, INO-3107, as a Potential Treatment for RRP
- INOVIO Reports Inducement Grants Under Inducement Plan
- INOVIO to Present at Upcoming Scientific Conferences
- INOVIO to Present at Upcoming Scientific Conference
- INOVIO Reports Second Quarter 2024 Financial Results and Recent Business Highlights
- INOVIO Reports Inducement Grant Under Inducement Plan
- Inovio Receives Advanced Therapy Medicinal Product Certificate from European Medicines Agency for Quality and Non-Clinical Data for Lead Candidate INO-3107
- INOVIO to Report Second Quarter 2024 Financial Results on August 8, 2024
- INO-3107 Awarded the Innovation Passport Designation Under U.K. Government's Innovative Licensing and Access Pathway
- INOVIO Announces Appointment of Steven Egge as Chief Commercial Officer
- INOVIO Reports Inducement Grant Under Inducement Plan
- INOVIO Added to Russell 2000® Index Effective July 1, 2024
- INOVIO to Participate in Virtual Fireside Chat Hosted by Stephens Inc.
- INOVIO Reports Inducement Grants Under Inducement Plan
- INOVIO Reports First Quarter 2024 Financial Results and Recent Business Highlights
- INOVIO Reports Inducement Grants Under Inducement Plan
- INOVIO to Report First Quarter 2024 Financial Results on May 13, 2024
- INOVIO to Participate in Upcoming Investor Conferences in May
- INOVIO Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
- INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn Medicine
- INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
- INOVIO to Report Fourth Quarter and Year-End 2023 Financial Results on March 6, 2024
